|
Pharmacokinetics of factors IX, recombinant human activated factor VII and factor XIII.
Haemophilia. 2006 Nov; 12(Suppl 4):61-9.
Poon MC. |
|
Pharmacokinetics of recombinant factor VIII (Kogenate-FS((R))) in children and causes of inter-patient pharmacokinetic variability.
Haemophilia. 2006 Nov; 12(Suppl 4):40-9.
Barnes C, Lillicrap D, Pazmino-Canizares J, Blanchette VS, Stain AM,Clark D, Hensmen C, Carcao M. |
|
Pharmacokinetic studies of coagulation factors: relevance of plasma and extracellular volume and body weight.
Haemophilia. 2006 Nov; 12(Suppl 4):33-9.
Komwilaisak P, Blanchette V. |
|
Platelet activation in subjects carrying factor V Leiden or factor II A20210 mutations.
J Thromb Haemost. 2006 Nov; 4(11):2496-8.
Grandone E, Martinelli I, Margaglione M, Dragani A, Davi G. |
|
Thrombin generation, a function test of the haemostatic-thrombotic system.
Thromb Haemost. 2006 Nov; 96(5):553-61.
Hemker HC, Al Dieri R, De Smedt E, Beguin S. |
|
The risk of acute ischaemic heart disease in post menopausal women depends on von Willebrand factor and fibrinogen concentrations and blood group genotype.
J Thromb Haemost. 2006 Oct; Epub ahead of print Oct
Roest M, Voorbij HA, Barendrecht AD, Peeters PH, van der Schouw YT. |
|
Antithrombotic therapy for peripheral arterial disease.
Heart. 2006 Oct; Epub ahead of print Oct
Hackam DG, Eikelboom JW. |
|
The tissue factor pathway in ischemic stroke.
Blood Coagul Fibrinolysis. 2006 Oct; 17(7):527-532.
Adams MJ, Thom J, Hankey GJ, Baker R, Gilmore G, Staton J, Eikelboom JW. |
|
Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Paediatr Anaesth. 2006 Oct; 16(10):1042-6.
Brady KM, Blaine Easley R, Tobias JD. |
|
Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls.
Br J Haematol. 2006 Oct; 135(2):220-7.
Collins PW, Macchiavello LI, Lewis SJ, Macartney NJ, Saayman AG, Luddington R, Baglin T, Findlay GP. |
|
Thrombosis and thrombophilia in children: a systematic review.
Semin Thromb Hemost. 2006 Oct; 32(7):724-8.
Tormene D, Gavasso S, Rossetto V, Simioni P. |
|
Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management.
Hepatology. 2006 Oct; 44(4):1039-46.
Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, Tripodi A, Sanyal AJ; Coagulation in Liver Disease Group. |
|
Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
Thromb Haemost. 2006 Oct; 96(4):465-70.
Hoppe B, Tolou F, Dorner T, Kiesewetter H, Salama A. |
|
A novel assay for factor XIII based on cross-linking of synthetic peptides: analysis of different substrates.
Blood Coagul Fibrinolysis. 2006 Oct; 17(7):575-80.
Kusch M, Grundmann C, Keitel S, Seitz R, Konig H. |
|
Quality and reliability of routine coagulation testing: can we trust that sample?
Blood Coagul Fibrinolysis. 2006 Oct; 17(7):513-9.
Lippi G, Franchini M, Montagnana M, Salvagno GL, Poli G, Guidi GC. |
|
Thrombin inhibitors and anti-factor Xa agents in the treatment of arterial occlusion.
Curr Drug Targets. 2006 Oct; 7(10):1285-90.
Klauss V, Spannagl M. |
|
Cyclooxygenase inhibition and atherothrombosis.
Curr Drug Targets. 2006 Oct; 7(10):1275-84.
Sohn HY, Krotz F. |
|
Acquired von Willebrand syndrome: Diagnostic problems and therapeutic options.
Am J Hematol. 2006 Sep; Epub ahead of print Sep
Eikenboom JC, Tjernberg P, Van Marion V, Heering KJ. |
|
The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis.
Br J Haematol. 2006 Sep; Epub ahead of print Sep
Stefano VD, Martinelli I, Rossi E, Battaglioli T, Za T, Mannuccio Mannucci P, Leone G. |
|
Current concepts on the pathogenesis of the antiphospholipid syndrome.
Blood. 2006 Sep; Epub ahead of print Sep
Giannakopoulos B, Passam F, Rahgozar S, Krilis SA. |
